Does Adagrasib 200 Mg Tablet Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- CYP3A4 SUBSTRATES THAT PROLONG QT/POSACONAZOLE
- ADAGRASIB/LEVOKETOCONAZOLE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GEPIRONE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/DISOPYRAMIDE
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/CISAPRIDE
- STR 3A4 INHIB;ATAZAN;DARUN/COLCHICINE (FOR CARDIOPROTECTION)
- STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (> 10 MG)
- STRONG CYP3A4 INHIBITORS/MAVACAMTEN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PACRITINIB
- STR CYP3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (> 10 MG)
- STRONG CYP3A4 INHIBITORS/DARIDOREXANT
- STRONG CYP3A4 INHIB THAT PROLONG QT/ARTEMETHER;LUMEFANTRINE
- SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ALFUZOSIN
- STRONG CYP3A4 INHIBITORS/FINERENONE
- STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RANOLAZINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/IVABRADINE
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (>10.5 MG)
- STRONG CYP3A4 INHIBITORS/UBROGEPANT
- SELECTED STRONG CYP3A4 INHIBITORS/ALPRAZOLAM; TRIAZOLAM
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (> 50 MG)
- STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (> 40 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- SELECTED STRONG CYP3A4 INHIBITORS/ISAVUCONAZONIUM
- STRONG CYP3A4 INHIBITORS/NALOXEGOL
- QT PROLONGING AGENTS/ANAGRELIDE
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/AVANAFIL
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- SELECTED STRONG CYP3A4 INHIBITORS/ERGOT ALKALOIDS
- STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- SELECTED CYP3A4 INHIBITORS/ORAL MIDAZOLAM
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
- SELECTED STRONG CYP3A4 INHIBITORS/LURASIDONE
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/DRONEDARONE
- P-GP AND STRONG CYP3A4 INHIBITORS/RIVAROXABAN
- STRONG CYP3A4 INHIBITORS/TOLVAPTAN
- STRONG CYP3A4 INHIBITORS/SILODOSIN; TAMSULOSIN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/EPLERENONE
- STRONG CYP3A4 INHIBITORS/IRINOTECAN
- QT PROLONGING AGENTS/SERTINDOLE
- QT PROLONGING AGENTS/DROPERIDOL
- QT PROLONGING AGENTS/LEVOMETHADYL
- QT PROLONGING AGENTS/SPARFLOXACIN
- QT PROLONGING AGENTS/HALOFANTRINE
- QT PROLONGING AGENTS/PIMOZIDE
- QT PROLONGING AGENTS/BEPRIDIL
- SELECTED CYP3A4 INHIBITORS/LOVASTATIN; SIMVASTATIN
- STRONG CYP3A4 INHIBITORS/VARDENAFIL (>2.5 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ADAGRASIB/STRONG CYP3A4 INDUCERS
- ADAGRASIB/IVOSIDENIB
- ADAGRASIB/STRONG CYP3A4 INHIBITORS
- ADAGRASIB/STRONG CYP3A4 INHIBITORS THAT PROLONG QT
- ADAGRASIB/QT PROLONGING AGENTS
- CYP3A4 INHIBITORS AND SUBSTRATES THAT PROLONG QT/ENCORAFENIB
- QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG CYP3A4 INHIBITORS/CAPIVASERTIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- DUAL CYP2C9 AND CYP3A4 INHIBITORS THAT PROLONG QT/ETRASIMOD
- STRONG CYP3A4 OR MODERATE CYP2C9 INHIBITORS/ERDAFITINIB
- STRONG CYP3A4 INHIBITORS/REBOXETINE
- SELECTED CYP3A4 INHIBITORS/MEPERIDINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUIZARTINIB
- STRONG CYP3A4 INHIBITORS/PALOVAROTENE
- STRONG CYP3A4 INHIBITORS/TRETINOIN
- STRONG CYP3A4 INHIBITORS/LENIOLISIB
- STRONG CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG CYP3A4 INHIBITORS/SPARSENTAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- STRONG CYP3A4 INHIBITORS/PIRTOBRUTINIB
- ADAGRASIB/CYCLOSPORINE; SIROLIMUS
- ADAGRASIB/DIGOXIN; ETOPOSIDE
- ADAGRASIB/DESIPRAMINE; IMIPRAMINE
- ADAGRASIB/WARFARIN
- ADAGRASIB/SEL SENSITIVE 3A4 SUBSTRATES THAT PROLONG QT
- ADAGRASIB/SELECTED SENSITIVE CYP3A4 SUBSTRATES
- ADAGRASIB/HALOPERIDOL
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB
- DUAL STRONG CYP3A4 & P-GP INHIBITORS/FUTIBATINIB
- MYELOSUPPRESSIVE CYP3A4 INHIBITORS THAT PROLONG QT/CLOZAPINE
- SELECTED STRONG CYP3A4 INHIBITORS THAT PROLONG QT/TACROLIMUS
- SLT STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GILTERITINIB
- STRONG CYP3A4 INHIBITORS/MITAPIVAT
- STR 3A4 INHIB PROL QT/TOLTERODINE (>1 MG IR OR >2 MG ER)
- STRONG CYP3A4 INHIBITORS/RIVOCERANIB
- SLT STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ILOPERIDONE
- SLT STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MIDOSTAURIN
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
- STRONG CYP3A4 INHIBITORS/RUPATADINE
- STRONG CYP3A4 INHIBITORS/SURUFATINIB
- STRONG CYP3A4 INHIBITORS/AVACOPAN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/RIBOCICLIB
- STRONG CYP3A4 INHIBITORS/ATOGEPANT
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/MOBOCERTINIB
- STRONG 3A4 INHIBITORS THAT PROLONG QT/BEDAQUILINE;DELAMANID
- STRONG & MODERATE 3A4 INHIBITOR THAT PROLONG QT/FEXINIDAZOLE
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- STRONG CYP3A4 INHIBIT THAT PROLONG QT/PIMAVANSERIN (<=10 MG)
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/GLASDEGIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/TOREMIFENE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SUNITINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/PAZOPANIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/NILOTINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/LAPATINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/DASATINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CRIZOTINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/CERITINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/BOSUTINIB
- STRONG CYP3A4 INHIBITORS/VINFLUNINE
- STRONG CYP3A4 INHIBITORS/VINCRISTINE
- STRONG CYP3A4 INHIBITORS/VINBLASTINE
- STRONG CYP3A4 INHIBITORS/TOFACITINIB
- STRONG CYP3A4 INHIBITORS/SONIDEGIB
- STRONG CYP3A4 INHIBITORS/RUXOLITINIB
- STRONG CYP3A4 INHIBITORS/PONATINIB
- STRONG CYP3A4 INHIBITORS/PALBOCICLIB
- STRONG CYP3A4 INHIBITORS/PACLITAXEL
- STRONG CYP3A4 INHIBITORS/OLAPARIB
- STRONG CYP3A4 INHIBITORS/IXABEPILONE
- STRONG CYP3A4 INHIBITORS/IDELALISIB
- STRONG CYP3A4 INHIBITORS/ERLOTINIB
- STRONG CYP3A4 INHIBITORS/DOXORUBICIN
- STRONG CYP3A4 INHIBITORS/DOCETAXEL
- STRONG CYP3A4 INHIBITORS/DABRAFENIB
- STRONG CYP3A4 INHIBITORS/COBIMETINIB
- STRONG CYP3A4 INHIBITORS/CABOZANTINIB
- STRONG CYP3A4 INHIBITORS/CABAZITAXEL
- STRONG CYP3A4 INHIBITORS/AXITINIB
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/SUVOREXANT
- QT PROLONGING AGENTS/LEVOMEPROMAZINE
- DUAL STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
- STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/VEMURAFENIB
- SELECT MODERATE CYP2D6 INHIBITORS/TAMOXIFEN
- STRONG CYP3A4 INHIBITORS/LURBINECTEDIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/QUETIAPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/OSILODROSTAT
- STRONG CYP3A4 INHIBITORS/RIMEGEPANT
- STRONG CYP3A4 INHIBITORS/NIMODIPINE
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ROMIDEPSIN
- STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG CYP3A4 INHIBITORS/AVAPRITINIB
- SELECTED CYP3A4 INHIBITORS/SALMETEROL COMBINATIONS
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/NALDEMEDINE
- STRONG CYP3A4 INHIBITORS/ISTRADEFYLLINE
- STRONG & MOD CYP3A4 INHIBITOR THAT PROLONG QT/ORAL LEFAMULIN
- STRONG CYP3A4 INHIBITORS THAT PROLONG QT/ENTRECTINIB
- STRONG CYP3A4 INHIBITORS/FEDRATINIB
- STRONG CYP3A4 INHIBITORS/PEXIDARTINIB (200 MG)
- SELECTED STRONG CYP3A4 INHIBITORS/CLOPIDOGREL
- STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
- STRONG CYP3A4 INHIBITORS/LORLATINIB
- STRONG CYP3A4 INHIBITORS/DUVELISIB
- STRONG CYP3A4 INHIBITORS/ELAGOLIX
- STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- QT PROLONGING AGENTS/LOFEXIDINE
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- QT PROLONGING AGENTS/MACIMORELIN
- STRONG CYP3A4 INHIBITORS/IBRUTINIB
- STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
- STRONG CYP3A4 INHIBITORS/ABEMACICLIB
- STRONG CYP3A4 INHIBITORS/COPANLISIB
- QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
- STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
- QT PROLONGING AGENTS/HYDROXYCHLOROQUINE
- STRONG CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- SLT STRONG 3A4 INHIBITORS/SILDENAFIL(PAH);TADALAFIL(BPH,PAH)
- QT PROLONGING AGENTS/HYDROXYZINE
- STRONG CYP3A4 INHIBITORS/VENETOCLAX
- QT PROLONGING AGENTS/TELAVANCIN
- QT PROLONGING AGENTS/SORAFENIB
- QT PROLONGING AGENTS/ONDANSETRON
- QT PROLONGING AGENTS/LENVATINIB
- QT PROLONGING AGENTS/GADOFOSVESET
- QT PROLONGING AGENTS/EZOGABINE
- QT PROLONGING AGENTS/OSIMERTINIB
- STRONG CYP3A4 INHIBITORS/TRABECTEDIN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/CARIPRAZINE
- SLT STRONG CYP3A4 INHIBITOR & SUBSTRATE/LUMACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
- STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
- STRONG CYP3A4 INHIBITORS/DACLATASVIR
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/VORAPAXAR
- QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG CYP3A4 INHIBITORS/MACITENTAN
- DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
- STRONG AND MODERATE CYP3A4 INHIBITORS/BOSENTAN
- P-GP AND STRONG CYP3A4 INHIBITORS/APIXABAN
- STRONG CYP3A4 INHIBITORS/REGORAFENIB
- STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- SELECTED MYELOSUPPRESSIVE AGENTS/DEFERIPRONE
- QT PROLONGING AGENTS/PROPAFENONE
- QT PROLONGING AGENTS/QUININE
- SELECTED STRONG CYP3A4 INHIBITORS/SALMETEROL
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/EVEROLIMUS
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- QT PROLONGING AGENTS/ZUCLOPENTHIXOL
- STRONG CYP3A4 INHIBITORS/MARAVIROC
- QT PROLONGING AGENTS/PALIPERIDONE
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- STRONG CYP3A4 INHIBITORS/COLCHICINE
- SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
- SELECTED CYP3A4 INHIBITORS/SELECTED STEROIDS
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ADAGRASIB/POSSIBLE QT PROLONGING AGENTS
- STRONG CYP3A4 INHIBITORS/VAMOROLONE
- SLT STRONG CYP3A4 INHIBIT/AMLODIPINE; LEVAMLODIPINE
- STRONG CYP3A4 INHIBITORS/ZURANOLONE
- STR CYP3A4 INHIB;ATAZAN;DARUNAV/SLT LONG-ACTING ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/BORTEZOMIB
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (=< 40 MG)
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (<=10.5 MG)
- STR 3A4 INHIBITORS THAT PROLONG QT/PANOBINOSTAT (<= 10 MG)
- STR 3A4 INHIB THAT PROL QT/TOLTERODINE (<=1 MG OR <=2 MG ER)
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
- STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
- STRONG CYP3A4 INHIBITORS/REPAGLINIDE
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
- STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/MEFLOQUINE
- STRONG CYP3A4 INHIBITORS/ZANUBRUTINIB
- DUAL P-GP AND STRONG CYP3A4 INHIBITORS/DAROLUTAMIDE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/BREXPIPRAZOLE
- QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- STRONG CYP3A4 INHIBITORS/CLONAZEPAM
- SELECTED CYP3A4 INHIBITORS/FELODIPINE
- STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
- STRONG CYP3A4 INHIBITORS/VARDENAFIL (<=2.5 MG)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
- SLT STRONG CYP3A4 INHIBIT/SELECTED CALCIUM CHANNEL BLOCKERS
- STRONG CYP3A4 INHIBITORS/BUSPIRONE
- STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
- STRONG CYP3A4 INHIBITORS/CINACALCET
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
- STRONG & MOD 3A4 INHIB THAT PROLONG QT/CILOSTAZOL (<=50MG)
- SLT STRONG CYP3A4 INHIBITORS/SILDENAFIL (ED); TADALAFIL (ED)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.